Study terminated early for business reasons

The purpose of this study is to monitor the performance of the DePuy PROXIMA™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Inclusion Criteria:

• Male or female subjects between 18 and 70 years of age.
• Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
• Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and agree to return to the hospital for all the required post-operative follow-ups.
• Subjects who are scheduled to undergo a primary THR whom the surgeon considers to be suitable for the DePuy PROXIMATM hip femoral prosthesis.

Exclusion Criteria:

• Subjects with active local or systemic infection
• Subjects with loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.
• Subjects with poor bone quality, such as osteoporosis, where, in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of fracture of the femoral shaft and/or the lack of adequate bone to support the implant(s).
• Subjects with Charcot's or Paget's disease.
• Subjects with hip dysplasia with severe neck anteversion or severe dysplasia of the proximal femur.
• Subjects with severe osteoporosis.
• Subjects with previous proximal femoral fractures.
• Subjects who, in the opinion of the Investigator, have an existing condition/co-morbidity or infection that would compromise their long-term participation and follow-up in this study.
• Women who are pregnant.
• Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
• Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
• Subjects who are currently involved in any injury litigation claims.
• Subjects for whom the surgical procedure is a revision of a previous THR, hemi-arthroplasty or hip resurfacing
• Subjects who have previously undergone osteotomy or arthrodesis of the hip.
• Subjects undergoing a simultaneous bilateral hip operation.
• Subjects undergoing the second stage of a staged bilateral for whom the contralateral hip is part of this clinical investigation.
• Subjects undergoing the second stage of a staged bilateral for whom the contralateral hip was implanted less than six months previously or is not performing satisfactorily